Humacyte, Inc. - *W EXP 08/27/202 (HUMAW)

Historical Portfolio Holders from Q3 2021 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / *W EXP 08/27/202
Shares, excl. options Q2 2024
901K
Holdings value Q2 2024
$1.26M
Value change Q2 2024
+$411K
Grand Portfolio weight change Q2 2024
+0%
Number of holders
10
Number of buys Q2 2024
7
Number of sells Q2 2024
-2
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 901K $1.26M +$411K $1.39 11
2024 Q1 639K $384K -$22.7K $0.60 8
2023 Q4 800K $333K -$33K $0.42 11
2023 Q3 866K $573K -$23K $0.72 11
2023 Q2 913K $660K +$187K $0.73 10
2023 Q1 636K $381K -$89.5K $0.60 10
2022 Q4 925K $448K +$9.44K $0.39 12
2022 Q3 722K $808K -$187K $1.11 11
2022 Q2 916K $810K +$190K $0.88 11
2022 Q1 635K $1.23M -$532K $1.94 12
2021 Q4 912K $2.33M +$701K $2.28 17
2021 Q3 528K $1.54M +$1.54M $2.90 14